Back to Results
First PageMeta Content
Cell biology / Cloning / Biology / Stem cells / Biotechnology


VistaGen  Therapeutics  Becomes  Member  of   Centre  for  Commercialization  of  Regenerative  Medicine  (CCRM)  Consortium     SOUTH   SAN   FRANCISCO,   CA   –
Add to Reading List

Document Date: 2012-12-06 13:14:14

Open Document

File Size: 72,24 KB

Share Result on Facebook

City

SOUTH SAN FRANCISCO / Atlanta / Toronto / /

Company

Therapeutics Inc. / Pfizer / VistaGen / GE Healthcare / Lonza / /

Country

Canada / /

Currency

USD / /

/

Event

Business Partnership / FDA Phase / /

Facility

University Health Network / Ontario Cancer Institute / University of Toronto / /

IndustryTerm

cell technologies / chemical variants / animal systems / pharmaceutical / stem cell technology / healthcare system / biotechnology company applying human pluripotent stem cell technology / pluripotent stem cell systems / biotechnology company applying stem cell technology / pluripotent stem cell technology / foundational technologies / /

MedicalCondition

serious and chronic condition causing pain / injury / disease / pain / infectious diseases / /

Organization

National Institute of Health / Centre for Commercialization / Securities and Exchange Commission / University of Toronto / /

Person

Singh / Keller / May / /

/

Position

Chief Executive Officer / Scientist / CEO / Governor / Professor / Director of the McEwen Centre / /

Product

Human Clinical Trials / AV / /

ProvinceOrState

Georgia / Ontario / /

Technology

drug metabolism / AV / pluripotent stem cell technology / biotechnology company applying stem cell technology / transplantation / stem cell technology / biotechnology company applying human pluripotent stem cell technology / drug discovery / biomaterials / cell technologies / drug development / Regenerative Medicine / /

URL

www.sec.gov / http /

SocialTag